Fifteen years ago, Pfizer established its skills-based volunteer program that takes a collaborative approach to deliver on its commitment to address pressing health needs in underserved communities around the world. Through this unique initiative, 490 Pfizer colleagues have contributed their diverse expertise and time in 50 countries to work with more than 70 partner organizations on projects aimed at strengthening health systems.
Gene therapy has the potential to transform how we manage rare genetic diseases like hemophilia, Duchenne Muscular Dystrophy and others by addressing their root cause – genetic mutations.
The Power of Science behind gene therapy inspires our colleagues, like Bob Smith, SVP, Global Gene Therapy Business, to investigate this groundbreaking technology that could, if successful, bring disease-modification to millions of patients worldwide.
By Oonagh Puglisi, Director, Corporate Responsibility at Pfizer Inc. and Executive Director of the Pfizer Foundation
When most people think of South by Southwest (SXSW), they might picture the latest high-tech gadgets, or a popular band playing at a sold-out concert.
For Pfizer Inc. and Rise Against Hunger, however, the annual music, film and technology festival in Austin, Texas, also served as something else: an opportunity to fight global hunger and support progress toward our shared goal of a more prosperous future.
Today on World Water Day, we are reflecting on all the ways Pfizer is working to reduce and preserve water across our company, contributing to the achievement of Sustainable Development Goal 6: Clean Water and Sanitation.
Pfizer released its 2017 Annual Review, which highlights how The Power of Science drives every aspect of Pfizer’s business in its mission to deliver innovative medicines and vaccines that help improve health and well-being at every stage of life.
This year’s integrated report uses the lens of our colleagues to illustrate how The Power of Science inspires the work they do every day. Highlights include:
Health impacts multiple aspects of women’s daily lives, yet many lack access to quality care. In support of the United Nations Sustainable Development Goals, we at Pfizer are committed to advancing Global Goal 5, gender equality, by improving access to equitable healthcare for women in underserved communities.
We’re proud to share that we have joined the Aspen Management Partnership for Health (AMP Health) and its network of partners to help strengthen community health systems in Africa by increasing access to quality healthcare. With our support, AMP Health will be able to scale its existing programs in Malawi, Kenya, and Sierra Leone by building the capacity and leadership necessary to set in place critical systems of thousands of community health workers.
In many low- and middle-income countries, it can be difficult for people living with non-communicable diseases (NCDs) to access the care they need. Those living with NCDs – like cancer, diabetes, cardiovascular diseases, chronic respiratory diseases, and mental health conditions – often struggle to take care of themselves and their loved ones. And the situation becomes even more burdensome with age.
Every day, thousands of individuals work in different capacities toward the global elimination of trachoma, a neglected tropical disease (NTD) and the world’s leading infectious cause of blindness. From manufacturing the antibiotic used to help treat trachoma, to distributing medication in affected communities, to performing surgery on those suffering from trichiasis, the blinding stage of trachoma, the roles in the fight to eliminate this disease are wide-ranging.